XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2019                   38,525,636                
Balance at Dec. 31, 2019 $ 0 $ 413 $ (413) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 385 $ 276,827 $ (46,145) $ (4,568) $ 475 $ (1,929) $ 225,045 $ 46,739 $ 271,784
Issuance of common stock (in shares)                   1,684,663                
Issuance of common stock                   $ 16 7,993 0 0 0 0 8,009 0 8,009
Warrant expenses                   0 763 0 0 0 0 763 0 763
Net income (loss)                   0 0 (31,774) 0 0 0 (31,774) 605 (31,169)
Other comprehensive loss for the period                   0 0 0 (3,665) (680) (1,006) (5,351) (1,624) (6,975)
Share-based compensation expenses                   $ 0 209 0 0 0 0 209 0 209
Balance (in shares) at Jun. 30, 2020                   40,210,299                
Balance at Jun. 30, 2020                   $ 401 286,205 (78,332) (8,233) (205) (2,935) 196,901 45,720 242,621
Balance (in shares) at Dec. 31, 2019                   38,525,636                
Balance at Dec. 31, 2019 $ 0 $ 413 $ (413) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 385 276,827 (46,145) (4,568) 475 (1,929) 225,045 46,739 $ 271,784
Balance (in shares) at Dec. 31, 2020                   40,453,462               40,453,462
Balance at Dec. 31, 2020                   $ 405 288,700 (85,543) (4,529) (8) (2,749) 196,276 50,606 $ 246,882
Balance (in shares) at Mar. 31, 2020                   38,541,724                
Balance at Mar. 31, 2020                   $ 385 277,852 (73,115) (8,960) (197) (1,696) 194,269 47,478 241,747
Issuance of common stock (in shares)                   1,668,575                
Issuance of common stock                   $ 16 7,950 0 0 0 0 7,966 0 7,966
Share-based compensation expenses                   0 (82) 0 0 0 0 (82) 0 (82)
Warrant expenses                   0 485 0 0 0 0 485 0 485
Net income (loss)                   0 0 (5,217) 0 0 0 (5,217) 29 (5,188)
Other comprehensive loss for the period                   $ 0 0 0 727 (8) (1,239) (520) (1,787) (2,307)
Balance (in shares) at Jun. 30, 2020                   40,210,299                
Balance at Jun. 30, 2020                   $ 401 286,205 (78,332) (8,233) (205) (2,935) 196,901 45,720 $ 242,621
Balance (in shares) at Dec. 31, 2020                   40,453,462               40,453,462
Balance at Dec. 31, 2020                   $ 405 288,700 (85,543) (4,529) (8) (2,749) 196,276 50,606 $ 246,882
Issuance of common stock (in shares)                   342,717                
Issuance of common stock                   $ 3 1,280 0 0 0 0 1,283 0 1,283
Warrant expenses                   0 830 0 0 0 0 830 0 830
Net income (loss)                   0 0 (5,270) 0 0 0 (5,270) 3,535 (1,735)
Other comprehensive loss for the period                   0 0 0 (1,968) 8 (352) (2,312) (69) (2,381)
Share-based compensation expenses                   $ 0 591 0 0 0 0 591 0 $ 591
Balance (in shares) at Jun. 30, 2021                   40,796,179               40,796,179
Balance at Jun. 30, 2021                   $ 408 291,401 (90,813) (6,497) 0 (3,101) 191,398 54,072 $ 245,470
Balance (in shares) at Mar. 31, 2021                   40,781,804                
Balance at Mar. 31, 2021                   $ 408 290,646 (97,698) (5,621) 0 (3,064) 184,671 52,837 237,508
Issuance of common stock (in shares)                   14,375                
Issuance of common stock                   $ 0 39 0 0 0 0 39 0 39
Share-based compensation expenses                   0 311 0 0 0 0 311 0 311
Warrant expenses                   0 405 0 0 0 0 405 0 405
Net income (loss)                   0 0 6,885 0 0 0 6,885 1,235 8,120
Other comprehensive loss for the period                   $ 0 0 0 (876) 0 (37) (913) 0 $ (913)
Balance (in shares) at Jun. 30, 2021                   40,796,179               40,796,179
Balance at Jun. 30, 2021                   $ 408 $ 291,401 $ (90,813) $ (6,497) $ 0 $ (3,101) $ 191,398 $ 54,072 $ 245,470